Viewing StudyNCT03552029



Ignite Creation Date: 2024-05-06 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 12:47 PM
Study NCT ID: NCT03552029
Status: TERMINATED
Last Update Posted: 2022-05-20
First Post: 2018-05-17

Brief Title: Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia AML
Sponsor: Daiichi Sankyo
Organization: Daiichi Sankyo

Organization Data

Organization: Daiichi Sankyo
Class: INDUSTRY
Study ID: DS3032-A-U105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Daiichi Sankyo
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators